# Local Injection of Ozone Versus Methylprednisolone Acetate in Carpal Tunnel Syndrome of Scleroderma Patients

> **NCT03742466** · NA · COMPLETED · sponsor: **Assiut University** · enrollment: 50 (actual)

## Conditions studied

- Carpal Tunnel Syndrome
- Chronic Pain
- Scleroderma

## Interventions

- **DRUG:** Ozone
- **DRUG:** methylprednisolone acetate

## Key facts

- **NCT ID:** NCT03742466
- **Lead sponsor:** Assiut University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-11-10
- **Primary completion:** 2019-07-30
- **Final completion:** 2019-09-30
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2020-08-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03742466

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03742466, "Local Injection of Ozone Versus Methylprednisolone Acetate in Carpal Tunnel Syndrome of Scleroderma Patients". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT03742466. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*